Zinger Key Points
- Tilray expands its non-alcoholic craft beer brand, Runner's High, to 4,500 new retail locations, including major chains.
- Tilray launches Tilray Craft in Germany, offering high-THC, terpene-rich cannabis products for medical use.
- Join Chris Capre on Sunday at 1 PM ET to learn the short-term trading strategy built for chaotic, tariff-driven markets—and how to spot fast-moving setups in real time.
Tilray Brands, Inc. TLRY shares are trading nearly flat on Wednesday.
The company’s stock is rising following two significant announcements today and yesterday. On Wednesday, the company revealed a significant expansion for Runner’s High Brewing, its non-alcoholic craft beer brand, which will now be available at 4,500 new distribution points.
This includes major retailers such as Publix, HEB, Harris Teeter, and Lowes Foods.
With this expansion, Tilray aims to make Runner’s High a go-to beverage for runners and beer lovers alike.
The brand offers three varieties: Golden Wheat, Raspberry Wheat, and Dark Chocolate, each low in calories and designed to appeal to health-conscious consumers.
Additionally, Runner’s High is reinforcing its position in the running community through a partnership with the Atlanta Track Club and participation in the world-renowned Peachtree Road Race this July.
In another move, Tilray introduced Tilray Craft yesterday, a new extension of its medical cannabis portfolio.
This brand, launched in Germany, will provide flower-based cannabis products with higher THC and terpene content for patients.
The latest product under the Tilray Craft brand is Cannabisblüten THC 25 TAM, a sativa-leaning hybrid strain.
According to Benzinga Pro, TLRY stock has lost over 63% in the past year. Investors can gain exposure to the stock via Amplify ETF Trust Amplify Alternative Harvest ETF MJ and AdvisorShares Pure Cannabis ETF YOLO.
Price Action: TLRY shares are trading lower by 0.22% to $0.6083 at last check Wednesday.
Read Next:
Image Source: Tilray Brands, Inc..
Edge Rankings
Price Trend
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!